Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Oropharyngeal candidiasis
Dose: Intravenous Injection – 200 mg on the first day, followed by 100 mg
Frequency: once daily
Duration: at least 2 weeks
Note: Treatment should be continued for at least 2 weeks to decrease the likelihood of relapse.
Indication: Esophageal candidiasis
Dose: Intravenous Injection – 200 mg on the first day, followed by 100 mg
Frequency: once daily
Duration: minimum of 3 weeks and for at least 2 weeks following resolution of symptoms
Note: Doses up to 400 mg/day may be used, based on medical judgment of the patient’s response to therapy.

Child Dose

Clinical InformationAdministration Information
Indication: Oropharyngeal candidiasis
Age: Children
Dose: Intravenous – 6 mg/kg
Frequency: once daily
Duration: first day
Note: Followed by 3 mg/kg once daily
Indication: Oropharyngeal candidiasis
Age: Children
Dose: Intravenous – 3 mg/kg
Frequency: once daily
Duration: at least 2 weeks
Note: Followed after 6 mg/kg on the first day to decrease the likelihood of relapse

Renal Dose

Clinical InformationAdministration Information
Condition: Haemodialysis
Dose: Dosage Form – Usual dose
Note: Dose given after each session
Condition: Renal impairment with Creatinine Clearance less than 50 ml/min and not receiving dialysis
Dose: Dosage Form – 50% of the usual dose
Administration
  • For hospital use only
  • Must be administered by healthcare professionals
Side Effect

Drug Interaction

Drug NameRisk Factors
Oral hypoglycaemics (e.g. tolbutamide, glyburide, glipizide), Phenytoin, Theophylline, Tofacitinib, Rifabutin
May increase plasma concentrations
Anticoagulants (Warfarin, Heparin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban)
May increase prothrombin time

Disease Interaction

Disease NameRisk Factors
Known Hypersensitivity
Risk of severe allergic reaction
Advanced Liver Disease
Can worsen liver function

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.